Skip to search formSkip to main contentSkip to account menu

Posaconazole:MCnc:Pt:Ser/Plas:Qn

Known as: Posaconazol:Massa concentratie:Moment:Serum of plasma:Kwantitatief, Posaconazole SerPl-mCnc, Posaconazola:MCnc:Pt:Sor/Plas:Qn 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objectives This study describes therapeutic drug monitoring (TDM) of posaconazole suspension and modified release (MR) tablets in… 
2018
2018
  • C. Fietz
  • 2018
  • Corpus ID: 86599291
Grau S et al. Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in… 
2017
2017
We report a case of posaconazole toxicity in a 44-year-old man with a history of diffuse large B cell lymphoma. He achieved… 
Review
2016
Review
2016
Abstract Invasive fungal infections are one of the major complications in pediatric patients during prolonged neutropenia after… 
2011
2011
Background: Posaconazole is an azole antifungal agent with a broad spectrum of activity and a manageable side-effect profile… 
Highly Cited
2008
Highly Cited
2008
ABSTRACT We compared the efficacy of combination posaconazole-liposomal amphotericin B (LAmB) therapy to monotherapy with either… 
Review
2008
Review
2008
Invasive fungal infections (IFIs) are a frequent, costly and potentially life-threatening complication in hematopoietic stem cell… 
2006
2006
Objective: To report a pediatric case of posttraumatic fungal fasciitis treated successfully with a combination including… 
Review
2005
Review
2005
Cerebral phaeohyphomycosis caused by Ramichloridium mackenziei is universally fatal. All reported cases with long-term follow-up…